期刊文献+

儿科的临床科研伦理问题及其解决方案综述 被引量:4

Review of Ethical Problems and Solutions in Pediatric Clinical Research
下载PDF
导出
摘要 临床科研中伦理问题受到广泛关注,尤其是患者数量多、医疗复杂性高的儿科。在知情同意中,做出同意的人在身份或能力上可能不适合而且知情不充分或者焦虑和压力等因素可能会影响其做出决定;在伦理审查中,儿科知情同意程序、儿童护理条件、报销赔偿标准复杂而且部分伦理委员会对儿科的特殊性了解不深;在儿科伦理咨询中,有关信息少、利用不充分、地域差异大。知情同意中的问题可由使用双重同意程序或评估儿童是否具有同意能力、研究员与做出同意的人沟通并强调风险并在特殊情况下使用延期同意解决;伦理审查中的问题可由建立中央伦理委员会并与社会伦理委员会合作、建立规范并进行培训解决;伦理咨询中的问题可由使用电子咨询、制定伦理咨询程序解决。 In clinical research,ethical issues have attracted wide attention,especially in pediatrics with a large number of patients and high medical complexity. In informed consent,the person who makes consent may not be suitable in identity or ability,and the factors such as insufficient knowledge,anxiety and pressure may affect his decision-making. In the ethical review,the procedure of informed consent in pediatrics,the conditions of child care and the standard of compensation for reimbursement are complicated,and some ethical committees do not have a deep understanding of the particularity of pediatrics. In pediatric ethical counseling,there are few relevant information,insufficient utilization and great regional differences. Problems in informed consent can be solved by using double consent procedure or assessing children’s ability to consent,communicating with consenting people and emphasizing risks,and using deferred consent in exceptional cases. The problems in ethical review can be solved by establishing a central ethics committee and cooperating with the social ethics committee,establishing norms and training,and the problems in ethical consultation can be solved by using electronic consultation and establishing ethical consultation procedures.
作者 郝婧如 臧云龙 傅丽丽 弓晓皎 姚卜凡 张逸晨 吴一波 HAO Jingru;ZANG Yunlong;FU Lili;GONG Xiaojiao;YAO Bufan;ZHANG Yichen;WU Yibo(School of Pharmacy, Shandong University, Jinan 250012, China;School of Business, Ningbo University, Ningbo 315211, China;Department of Social Work, Pediatric HospitalAffiliated to Fudan University, Shanghai 201102, China;Institute of Clinical Pharmacology, Sun Yat-senUniversity, Guangzhou 510006, China;Department of Clinical Pharmacy, School of Pharmacy, ShandongUniversity, Jinan 250012, China;Department of Pharmaceutical Administration and Clinical Pharmacy,School of Pharmacy, Peking University, Beijing 100191, China)
出处 《中国医学伦理学》 2019年第1期132-138,共7页 Chinese Medical Ethics
关键词 临床科研伦理 知情同意 伦理审查 伦理咨询 儿科 Clinical Research Ethics Informed Consent Ethical Review Ethical Consultation Pediatrics
  • 相关文献

参考文献1

二级参考文献11

  • 1US DHHS & FDA. Using a centralized IRB review process inmulticenter clinical trial [ EB/OL] . ( 2006 -03). http ://www.fda. gov/Regulatory Information/Guidances/ucml 27004. html.
  • 2国家食品药品监督管理局.关于印发“药物临床试验伦理审査工作指导原则”的通知[EB/OL]. (2010 - 11 -02). ht-tp://www. sda. gov. cn/WS01/CL0055/55613. html.
  • 3熊宁宁,李煜,汪秀琴,等.临床试验机构伦理委员会操作规程[M].科学出版社,2012:37 -42.
  • 4SILBERMAN G, KAHN KL. Burdens on research imposed byinstitutional review boards : the state of the evidence and its im-plications for regulatory reform [ J ]. Milbank Q, 2011,89 (4):599 -627.
  • 5ADA. Advance notice of proposed rulemaking ( ANPRM). [ EB/OL] . ( 2011 - 06 - 26 ). www. ada. gov/anprm2010/an-prm2010. htm.
  • 6PUTNEY SB. Central IRB review[R],南京:赛诺菲中国研发中心与江苏省人民医院临床研究及伦理高级培训班.2013.
  • 7UK. National research ethics service SOP. [ EB/OL] . [2013 -07 - 01 ]. http ://www. nres. nhs. uk/about-the-national-re-search-ethics-service/about-recs/different-types-of-rec.
  • 8翁新愚.英国伦理委员会的现状与分析[J].中国新药杂志,2008,17(19):1724-1727. 被引量:16
  • 9李恩昌,吉鹏程.多方合作 协调发展——生物医学研究伦理审查能力建设高峰论坛暨上海市医学伦理学会年会在沪举行[J].中国医学伦理学,2011,24(1):126-127. 被引量:4
  • 10胡庆澧,沈铭贤.努力提高多中心临床研究的伦理审查质量[J].医学与哲学(A),2011,32(5):2-5. 被引量:14

共引文献13

同被引文献42

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部